Europe Approves Avapritinib for Rare Mast Cell Disease

The drug targets a mast cell mutation that gives rise to indolent systemic mastocytosis, a rare and debilitating blood disorder.

Related Keywords

Germany , ,European Union ,European Commission ,Medicinal Products ,Human Use ,Rare Diseases ,Europe ,European ,Lysosomal Storage Disease ,Systemic Mastocytosis ,Blood ,I Cell Disease ,Ucolipidosis Type Ii ,Nclusion Cell Disease ,Ucolipidosis Ii ,Ol Ii ,Mastocytosis ,Bone Marrow ,Edulla Ossea ,Prabdominal ,Bones ,